Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 7 results

Author Title Type [ Year

]

Filters: Author is Cutler, Corey [Clear All Filters]

2019

Pidala, Joseph, Michael Martens, Claudio Anasetti, Jeanette Carreras, Mary Horowitz, Stephanie J Lee, Joseph Antin, Corey Cutler, and Brent Logan. 2019. “Factors Associated With Successful Discontinuation Of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation.”. Jama Oncol. Jama Oncol. doi:10.1001/jamaoncol.2019.2974.

2017

Zaid, Mohammad Abu, Juan Wu, Cindy Wu, Brent R Logan, Jeffrey Yu, Corey Cutler, Joseph H Antin, Sophie Paczesny, and Sung Won Choi. 2017. “Plasma Biomarkers Of Risk For Death In A Multicenter Phase 3 Trial With Uniform Transplant Characteristics Post-Allogeneic Hct.”. Blood 129 (2). Blood: 162-170. doi:10.1182/blood-2016-08-735324.

2016

Lee, Stephanie J, Brent Logan, Peter Westervelt, Corey Cutler, Ann Woolfrey, Shakila P Khan, Edmund K Waller, et al.. 2016. “Comparison Of Patient-Reported Outcomes In 5-Year Survivors Who Received Bone Marrow Vs Peripheral Blood Unrelated Donor Transplantation: Long-Term Follow-Up Of A Randomized Clinical Trial.”. Jama Oncol 2 (12). Jama Oncol: 1583-1589. doi:10.1001/jamaoncol.2016.2520.

2014

Cutler, Corey, Brent Logan, Ryotaro Nakamura, Laura Johnston, Sung Choi, David Porter, William J Hogan, et al.. 2014. “Tacrolimus/sirolimus Vs Tacrolimus/methotrexate As Gvhd Prophylaxis After Matched, Related Donor Allogeneic Hct.”. Blood 124 (8). Blood: 1372-7. doi:10.1182/blood-2014-04-567164.

2012

Ballen, Karen, Adam M Mendizabal, Corey Cutler, Ioannis Politikos, Katarzyna Jamieson, Elizabeth J Shpall, Bimalangshu R Dey, et al.. 2012. “Phase Ii Trial Of Parathyroid Hormone After Double Umbilical Cord Blood Transplantation.”. Biol Blood Marrow Transplant 18 (12). Biol Blood Marrow Transplant: 1851-8. doi:10.1016/j.bbmt.2012.06.016.

2008

Cutler, Corey, Kristen Stevenson, Haesook T Kim, Paul Richardson, Vincent T Ho, Erica Linden, Carolyn Revta, et al.. 2008. “Sirolimus Is Associated With Veno-Occlusive Disease Of The Liver After Myeloablative Allogeneic Stem Cell Transplantation.”. Blood 112 (12). Blood: 4425-31. doi:10.1182/blood-2008-07-169342.

2005

Ho, Vincent T, Corey Cutler, Shelly Carter, Paul Martin, Roberta Adams, Mary Horowitz, James Ferrara, Robert Soiffer, and Sergio Giralt. 2005. “Blood And Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation.”. Biol Blood Marrow Transplant 11 (8). Biol Blood Marrow Transplant: 571-5. doi:10.1016/j.bbmt.2005.06.001.